Urine cytology coupled with cystoscopic examination has been and remains the standard in
the initial evaluation of lower urinary tract lesions to rule out bladder cancer. However …

Background: Transitional cell carcinoma of the bladder (TCC) is the second most common
malignancy of the urinary tract. More than 70% of treated tumors recur, and 30% of recurrent …

PURPOSE: An experimental hematuria model was designed to determine whether the
bladder tumor antigen (BTA) stat test (Bion Diagnostics, Redmond, Washington) is …

BACKGROUND Cystoscopy and histologic examination remain the standard methods for
initial tumor diagnosis and monitoring for early detection of recurrences, since the sensitivity …

As is clear from the brief summary of available assays, the optimal method of application is
not yet clear. The integration of an assay into clinical practice takes more than just the …

The diagnosis of tumors of the urinary bladder and urinary tract account for 6% of new
cancer cases in men and 3% of new cancer cases in women in the US each year. 1, 2 Two …

Urinary polyomavirus subtype BK (BKV)-infected urothelial and renal tubular cells,“decoy
cells,” have been shown to be aneuploid with digital image analysis (DIA). We wanted to …

Importance of the field: A non-invasive marker for the follow-up and diagnosis of bladder
cancer is highly needed. Several markers have been studied with regard to sensitivity and …

PURPOSE: We determined whether deoxyribonucleic acid (DNA) ploidy analysis by image
analysis cytometry enhances the cytological diagnosis of recurrent transitional cell …

Background The ability to accurately predict tumor behavior and patient survival is a
problem in managing patients with prostate cancer. Prognostic variables in predicting death …